 |
|
Higher anaphylaxis rates after HPV vaccination: CMAJ study
September 02, 2008Despite higher rates, HPV vaccine safe for use
OTTAWA, ONTARIO, CANADA - The estimated rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher - 5 to 20 fold - than that identified in comparable school-based vaccination programs, according to a study published in CMAJ http://www.cmaj.ca/press/179_6_525.pdf However, the overall rates of anaphylaxis were low with no associated serious lasting effects.
In a study of 114,000 women, a team of Australian researchers found 12 suspected of anaphylaxis, and confirmed 8 of these, in a 2007 vaccination program in New South Wales, Australia. Symptoms included difficulty breathing, nausea and rashes.
Dr. Julia Brotherton and colleagues postulate that reasons for an increased rate of anaphylaxis may include possible allergic reaction to the vaccine components, enhanced adverse event surveillance, higher rates of anaphylaxis in women from midadolescence compared with men, and an apparent increase in incidence of anaphylaxis in Australia.
The estimated rate of anaphylaxis following HPV vaccination was 2.6 per 100,000 doses administered compared with a rate 0.1 per 100 000 doses administered in a 2003 school-based meningococcal C vaccination program.
HPV vaccination programs will begin this fall in the United Kingdom and other European countries as well as in parts of Canada and the United States.
Dr. Brotherton stresses "the importance of good training for staff administering vaccines in school or other settings in the recognition and management of suspected anaphylaxis and its reporting." They conclude that anaphylaxis following the HPV vaccine is rare and vaccine programs should continue.
Anaphylaxis is a rare but serious adverse event and highlights the importance of vaccine safety studies after vaccine licensing and careful management of reactions in immunization clinics, says Dr. Neal Halsey, Institute of Vaccine Safety, Johns Hopkins Bloomberg School of Public Health in a related commentary http://www.cmaj.ca/press/179_6_509.pdf He states "before concluding that the HPV vaccine is associated with higher rates of anaphylaxis than other vaccines everywhere, cases in other populations should be reviewed-.As of July 21, 2008, 11 cases have been reported [in the US] in 2008. Over 13 million doses of this vaccine have been distributed as of the end of 2007."
A CMAJ editorial http://www.cmaj.ca/press/179_6_503.pdf states that this study indicates the HPV vaccine is "remarkably safe." The study provides an excellent opportunity for Canada's public health community "to restart public discussions about the safety of the HPV vaccine, the precautions taken to mitigate risks if anaphylaxis occurs, and the care taken in surveillance for adverse events following vaccination," write Drs. Noni MacDonald, Matthew Stanbrook and Paul Hebert.
Canadian Medical Association Journal
Dr. Julia Brotherton and colleagues postulate that reasons for an increased rate of anaphylaxis may include possible allergic reaction to the vaccine components, enhanced adverse event surveillance, higher rates of anaphylaxis in women from midadolescence compared with men, and an apparent increase in incidence of anaphylaxis in Australia.
The estimated rate of anaphylaxis following HPV vaccination was 2.6 per 100,000 doses administered compared with a rate 0.1 per 100 000 doses administered in a 2003 school-based meningococcal C vaccination program.
HPV vaccination programs will begin this fall in the United Kingdom and other European countries as well as in parts of Canada and the United States.
Dr. Brotherton stresses "the importance of good training for staff administering vaccines in school or other settings in the recognition and management of suspected anaphylaxis and its reporting." They conclude that anaphylaxis following the HPV vaccine is rare and vaccine programs should continue.
Anaphylaxis is a rare but serious adverse event and highlights the importance of vaccine safety studies after vaccine licensing and careful management of reactions in immunization clinics, says Dr. Neal Halsey, Institute of Vaccine Safety, Johns Hopkins Bloomberg School of Public Health in a related commentary http://www.cmaj.ca/press/179_6_509.pdf He states "before concluding that the HPV vaccine is associated with higher rates of anaphylaxis than other vaccines everywhere, cases in other populations should be reviewed-.As of July 21, 2008, 11 cases have been reported [in the US] in 2008. Over 13 million doses of this vaccine have been distributed as of the end of 2007."
A CMAJ editorial http://www.cmaj.ca/press/179_6_503.pdf states that this study indicates the HPV vaccine is "remarkably safe." The study provides an excellent opportunity for Canada's public health community "to restart public discussions about the safety of the HPV vaccine, the precautions taken to mitigate risks if anaphylaxis occurs, and the care taken in surveillance for adverse events following vaccination," write Drs. Noni MacDonald, Matthew Stanbrook and Paul Hebert.
Canadian Medical Association Journal
Anaphylaxis Current Events and Anaphylaxis News RSSScientists developing food allergy treatment
A team of scientists from across Europe are embarking on new research to develop a treatment for food allergy.
Society's lack of food allergies impacts those afflicted with food allergies
The level of knowledge and understanding of children with food allergies varies significantly across three key groups: pediatricians and family physicians, the general public and families who have a child with food allergies. The article describing the new findings was published in the September issue of BioMed Central Pediatrics.
Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center.
Adverse reactions to antibiotics send thousands of patients to the ER
Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases.
Students with food allergies often not prepared
College students with food allergies aren't avoiding the foods they know they shouldn't eat. Students of all ages are not treated with potentially life-saving epinephrine as often as they should be. And instructors, roommates and friends often are not aware of what to do if a food-allergic student has a reaction.
Researchers find cause of severe allergic reaction to cancer drug
Clinicians have been perplexed by the fact that some patients given the drug cetuximab-an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer-have a severe and rapid adverse reaction to the drug.
Research Finds Allergic Children Exposed to Peanuts at Younger and Younger Ages Despite Recommendations To Avoid Until Age 3
The age at which children are exposed to peanuts and have an allergic response has dropped significantly over the last decade, despite recommendations that at-risk families avoid exposing children to peanuts during the first three years of life.
Abnormal immune cells may cause unprovoked anaphylaxis
Two new clinical reports shed light on why some people suffer from recurrent episodes of idiopathic anaphylaxis--a potentially life-threatening condition of unknown cause characterized by a drop in blood pressure, fainting episodes, difficulty in breathing, and wheezing.
Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
A blood cell known as a troublemaker for triggering the itch and inflammation in allergy attacks, the mast cell, can also calm down the flare-ups.
Experimental ragweed therapy offers allergy sufferers longer relief with fewer shots
Americans accustomed to the seasonal misery of sneezing, runny noses and itchy, watery eyes caused by ragweed pollen might one day benefit from an experimental allergy treatment that not only requires fewer injections than standard immunotherapy, but leads to a marked reduction in symptoms that persists for at least a year after therapy has stopped.
More Anaphylaxis Current Events and Anaphylaxis News Articles
 | Anaphylaxis: A Practical Guide by Philip Jevon This book is a small, yet comprehensive, practical guide to the management of anaphylaxis. It will equip any healthcare worker with the essential information they need to be able to respond quickly and appropriately in the event of an anaphylactic reaction, which can be life-threatening if not diagnosed and treated effectively. * Clear, concise writing style well supported by illustrations *... |
 | Anaphylaxis, An Issue of Immunology and Allergy Clinics (The Clinics: Internal Medicine) by P. Lieberman |
 | Clinical Management of Urticaria and Anaphylaxis (Allergic Disease and Therapy) by Schocket Examines the pathophysiology, diagnosis, and therapy of urticaria and anaphylaxis, providing practical approaches for understanding and managing clinical problems of these common, but often poorly understood, disorders.;This book is designed to be of interest to adult and paediatric allergists, dermatologists, clinical immunologists, internists, paediatricians, emergency care physicians and... |
 | Anaphylaxis (Novartis Foundation Symposia) by Novartis Foundation Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis.... |
| Allergy, Anaphylaxis and Immunotherapy, Basic Principles and Practice: a Treatise Presenting the Fundamental Principles and Practice Governing the Use of Antisera, Vaccines, Toxoids, Blood transfusions, blood substitutes and Sulfonamides, in the Prevention and Treatment of Infectious Diseases and of the Allergic Phenomena Resulting from Their Use by Bret Ratner | |
| Idiopathic Anaphylaxis by Roy Patterson, Roy, M.D. Patterson | |
| Permanent hair dye can cause anaphylaxis: itching, urticaria warning signs.(Women's Health): An article from: Family Practice News by Sherry Boschert This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2004. The length of the article is 405 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Give all anaphylaxis patients consistent care.(Clinical Rounds): An article from: Skin & Allergy News by Robert Finn This digital document is an article from Skin & Allergy News, published by International Medical News Group on June 1, 2004. The length of the article is 621 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Gale Encyclopedia of Medicine: Anaphylaxis by Richard Robinson The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major... | |
| THREE OFFPRINTS FROM THE 1919 HERTER LECTURES AT JOHNS HOPKINS UNIVERSITY: 1) CAPILLARY POISONS AND SHOCK. 2) ANAPHYLAXIS. 3) CHEMICAL STRUCTURE AND PHYSIOLOGICAL ACTION. by Henry Hallett. DALE |
| © 2008 BrightSurf.com |